PHYSICAL STABILITY AND PROTEIN STABILITY OF FREEZE-DRIED CAKES DURING STORAGE AT ELEVATED-TEMPERATURES

被引:53
作者
IZUTSU, KI
YOSHIOKA, S
KOJIMA, S
机构
[1] National Institute of Health Sciences, Setagaya-ku, Tokyo, 158
关键词
STORAGE; CRYSTALLIZATION; PROTEIN STABILITY; FREEZE-DRYING; EXCIPIENTS;
D O I
10.1023/A:1018931319772
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The relationship between physical stability of freeze-dried cakes and protein stability during storage was studied using beta-galactosidase as a model protein and inositol as an excipient. Amorphous samples freeze-dried from solutions containing the enzyme and various concentrations of inositol in sodium phosphate buffer (50 mM, pH 7.4) were stored for 7 days over P2O5 at 40 to 70 degrees C. Structural collapse and inositol crystallization were observed in some of the samples, depending on the formulation and storage temperature. The physical stability of freeze-dried samples was also studied by differential scanning calorimeter (DSC). Inositol showed a protein-stabilizing effect when its amorphous form was retained during storage, regardless of structural collapse. However, crystallization of inositol during storage removed its stabilizing effect. Addition of water-soluble polymers such as dextran, Ficoll and carboxymethyl cellulose sodium salt (CMC-Na) preserved activity of the enzyme by preventing inositol crystallization.
引用
收藏
页码:995 / 999
页数:5
相关论文
共 16 条
[1]   PROTEIN-SOLVENT INTERACTIONS IN PHARMACEUTICAL FORMULATIONS [J].
ARAKAWA, T ;
KITA, Y ;
CARPENTER, JF .
PHARMACEUTICAL RESEARCH, 1991, 8 (03) :285-291
[2]   SEPARATION OF FREEZING-INDUCED AND DRYING-INDUCED DENATURATION OF LYOPHILIZED PROTEINS USING STRESS-SPECIFIC STABILIZATION .1. ENZYME-ACTIVITY AND CALORIMETRIC STUDIES [J].
CARPENTER, JF ;
PRESTRELSKI, SJ ;
ARAKAWA, T .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 303 (02) :456-464
[3]   THE EFFECT OF CARBOHYDRATE ADDITIVES IN THE FREEZE-DRYING OF ALKALINE-PHOSPHATASE [J].
FORD, AW ;
DAWSON, PJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (02) :86-93
[4]  
FRANKS F, 1990, CRYO-LETT, V11, P93
[5]  
Gatlin L, 1980, J Parenter Drug Assoc, V34, P398
[6]  
HANSON MA, 1992, STABILITY PROTEIN B, P209
[7]  
IZUTSU K, 1991, INT J PHARM, V71, P137
[8]  
IZUTSU K, 1993, INT J PHARM, V90, P187
[9]  
IZUTSU K, 1993, PHARM RES, V10, P1233
[10]   STABILITY OF PROTEIN PHARMACEUTICALS [J].
MANNING, MC ;
PATEL, K ;
BORCHARDT, RT .
PHARMACEUTICAL RESEARCH, 1989, 6 (11) :903-918